-
Most Recent
Biotech Stocks
Biotech is defined as using technology to change, manipulate, and harness biological processes in order to fulfill a medical need. The applications of biotech are endless and range from genetically modifying foods to creating vaccines. During the height of the coronavirus pandemic, companies like Moderna and BioNTech utilized biotech to create life-saving vaccines that were distributed across the globe.
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
3 Promising Biotech Stocks for the Long-Term: August 2024
Some of the best biotech opportunities can be found in oversold obesity treatment stocks. Here are just a few.
The 3 Best Healthcare Stocks to Buy in August 2024
These are the best healthcare stocks that could bring in massive returns to the investors in the future. Do not miss out on this opportunity.
Other industries you might be interested in
Recent Biotech Stocks Articles
7 Biotech Stocks to Buy
With an aging U.S. population in need of healthcare, biotech stocks will grow with the demographic, providing an excellent chance to buy these 7 stocks.
Amgen’s Stochastic Issues Buy Signal
Amgen has been consolidating with support around its 50-day moving average. Get the target for AMGN.
Here Comes a Bidding War for Amylin
Approval of its diabetes drug has Big Pharma banging on its door, with Bristol-Myers Squibb already said to have offered $3.5 billion, or $22 per share.
4 Biotech ETFs for a Healthy Portfolio
The sector is coming back strong, and a diversified ETF is the best way to play it.
My 2 Favorite Stocks for This Week
These two small caps -- in biotech and microelectronics -- have cutting-edge technology and would make great takeover targets.
Generic Versions of Boniva Approved By the FDA
The FDA approved the first generic versions of osteoporosis drug Boniva, allowing manufacturers like Apotex, Orchid Healthcare and Mylan to make the drug.
9 Pharma Buys for a Healthy Portfolio
Their dividends are attractive, and some drugmakers have made great progress in refilling their pipelines.
Why Investors Needn’t Fear the ‘Patent Cliff’
Expiring drug patents can cost pharma stocks billions of dollars, but companies and investors alike can prepare themselves well in advance.
6 Dividend Stocks You Need to Watch
Utilities, a REIT, a pharma, a bond fund and a preferred fund that are worth keeping an eye on.
FDA Considers Waiving Prescription Requirement for Key Drugs
The FDA is considering a proposal to waive the prescription requirement for key drugs and encourage easy access to computer-supported self-diagnostic tools.
10 Pharma Blue Chips to Buy
There are a number of great companies in pharma if you know where to look.
4 Stocks to Watch on Dendreon Earnings
Here's a look at how to trade Dendreon on Monday's earnings report, as well as similar smaller companies that tend to move when DNDN moves.
5 Ways Alex Gorsky Can Heal Ailing J&J
Here's why Alex Gorsky, former captain in the U.S. Army Rangers, has what it takes to lead the health-care giant out of its morass.
5 Top Biotech Stocks Providing Healthy Returns
The fundamental and quantitative results from analyzing these five biotech stocks are impressive.
Why Illumina’s Future Remains Bright
Rejection of Roche's takeover bid has cooled ILMN shares, but many expect Roche to step up its advances. If not, Illumina still has great growth prospects.
2 Stocks to Watch for the Earnings Junkies
Canadian oil extractor Cenovus and international pharmaceutical company Teva announced positive earnings reports lately. See how they each stack up.
A Biotech That May Boost an Anemic Portfolio
Celgene Corp. is in an aggressive bull market and recently flashed another buy signal. Get the target for CELG.
Overreacting to a Prostate Cancer Drug?
Medivation shares are soaring on positive test results. But investors may be getting ahead of reality here.
